The estimated Net Worth of Rita A Karachun is at least $7.58 Milion dollars as of 3 May 2023. Ms. Karachun owns over 17,627 units of Merck & Co Inc stock worth over $7,064,301 and over the last 11 years she sold MRK stock worth over $516,262. In addition, she makes $0 as Senior Vice President Finance - Global Controller at Merck & Co Inc.
Rita has made over 21 trades of the Merck & Co Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently she exercised 17,627 units of MRK stock worth $1,192,290 on 3 May 2023.
The largest trade she's ever made was exercising 64,662 units of Merck & Co Inc stock on 14 February 2019 worth over $3,825,404. On average, Rita trades about 5,465 units every 100 days since 2014. As of 3 May 2023 she still owns at least 61,584 units of Merck & Co Inc stock.
You can see the complete history of Ms. Karachun stock trades at the bottom of the page.
Rita A. Karachun serves as Senior Vice President Finance - Global Controller of the Company. She is responsible for the Company’s global controller’s organization including all accounting, controls, external reporting and financial standards and policies. She has served as Assistant Controller of the Company since November 2009. Prior to her appointment as Assistant Controller of the Company, Ms. Karachun served as the Assistant Controller of Schering-Plough Corporation since February 2007 and was responsible for preparing financial statements and for the worldwide consolidation of international entities.
Rita Karachun is 56, she's been the Senior Vice President Finance - Global Controller of Merck & Co Inc since 2014. There are 19 older and 8 younger executives at Merck & Co Inc. The oldest executive at Merck & Co Inc is Thomas Cech, 73, who is the Independent Director.
Rita's mailing address filed with the SEC is C/O COHERUS BIOSCIENCES, INC., 333 TWIN DOLPHIN DRIVE, SUITE 600, REDWOOD CITY, CA, 94065.
Over the last 15 years, insiders at Merck & Co Inc have traded over $138,980,380 worth of Merck & Co Inc stock and bought 48,209 units worth $1,563,736 . The most active insiders traders include Wendell P Weeks, Kenneth C Frazier a Douglas M Jr Baker. On average, Merck & Co Inc executives and independent directors trade stock every 15 days with the average trade being worth of $5,050,222. The most recent stock trade was executed by Chirfi Guindo on 5 August 2024, trading 36,901 units of MRK stock currently worth $4,250,995.
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada.
Merck & Co Inc executives and other stock owners filed with the SEC include: